BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Bloodhound Technologies created a SaaS (Software as a Service) delivery platform aimed at helping healthcare payers control fraud and waste through a real-time claims processing environment.
Sold in 2011 to Verisk Analytics, Bloodhound customers included commercial health plans, state Medicaid agencies, and third-party administrators (TPAs) focused on combatting healthcare fraud through an emphasis on real-time adjudication, transparency for all participants in the claims cycle, business intelligence, and increased auto-adjudication and processing efficiencies.
Website
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.